Alkem Laboratories shares fell 5% after Q4FY25 results showed a modest 4.2% profit rise to Rs 306 crore and margin contraction to 12.4%. While Jefferies downgraded the target to Rs 4,460 citing weak margins, Nomura maintained a ‘Buy’ with a Rs 5,430 target. The company expects high single-digit revenue growth in FY26 and rising tax rates in FY27.
12 equity mutual funds with over Rs 1,000 NAV offer upto 24% CAGR since their inception. Do you own any?
Out of these 12 funds, 11 have been in the market for more than 25 years. They have delivered consistent double-digit returns over decades, highlighting